WHO ICTRP trial
International multicenter, open-label clinical trial for the treatment of acute…
CTIS2022-500783-35-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2022-500783-35-00 |
|---|---|
| Public title | International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents |
| Scientific title | International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents - AIEOP-BFM AML 2020 |
| Primary sponsor | Gpoh Gemeinnützige GmbH |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use - (Phase IV): no |
| Countries | Germany;Austria;Poland;Italy;Czechia;Greece |
| Conditions | Acute Myeloid Leukemia;Therapeutic area: Diseases [C] - Neoplasms [C04] |
| Interventions | Product Name: IDARUBICIN HYDROCHLORIDE,Product Code: SUB02635MIG,Pharmaceutical Form: SOLUTION FOR INJECTION,Other descriptive name: ,Strength: 10mg / 10mL,Product Code: SCP1037684,Pharmaceutical Form: ,Other descriptive name: ,Product… |
| Registration date | Aug 6, 2022 |
| Target size | 1091 |
| Secondary IDs | DRKS00024079 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: